in specific clinical scenarios could substantially reduce imaging costs [2] .
Paradoxically, insurers have recently raised concerns of MSK US overutilization [3] . In particular, wide availability and relatively low cost of US technology have led to widespread proliferation of US units and potential for overutilization. Primary care specialties were aggregated for data analysis. For the purposes of this study, "primary care" specialties include family practice, general practice, general internal medicine, and osteopathic providers. Specialties using more than three percent of total procedural volume were reported separately. All providers utilizing less than three percent of total volume were aggregated as "all other providers." Nonradiologist market share was defined as the utilization rate by nonradiologists per total MSK US utilization rate. We also determined growth rates and new procedure volume accrued by each specialty between 2000 and 2009.
To evaluate for possible substitution effects, the total volume and rate of musculoskeletal MR (MSK MR) examinations were also tabulated. Ultrasound continues to be a much less expensive imaging modality than MRI.
Given that there is similar accuracy between US and MRI for the diagnosis of certain MSK conditions such as rotator cuff tears, the literature supports the cost effectiveness of MSK US [5] . Parker, et al estimated that, in the Medicare population, the substitution of MSK US for MSK MRI, when appropriate, would lead to savings of more than $6.9 billion in the period from 2006 to 2020 [6] .
Given the large increases in both MSK US and MSK MR volume reported in our study, we find no significant evidence of MSK MR being substituted for MSK US.
Potential cost savings resulting from the substitution of MSK US for MSK MR could be negated if US is overutilized. On September 1, 2009, Blue Cross / Blue Shield insurers in Illinois, New Mexico, Oklahoma, and Texas issued the "Non-Operative
Spinal and Musculoskeletal Ultrasound, RAD602.016" policy that changed the classification of MSK US studies covered by CPT code 76880 to "experimental" [7] . Some of the motivation behind this decision may have been recent increases in MSK US utilization. After much advocacy, education and discussion, this policy was reversed 5 months later. However, increases in MSK US utilization remain of significant concern.
Although overutilization is difficult to define, it has been consistently demonstrated that provider specialty and situations that permit self-referral for imaging may impact the costs experienced by the healthcare system.
Numerous studies have shown that supplier induced demand leads to increased numbers of imaging studies when persons performing the examinations have a financial stake in doing so [8, 9, 10, 11, 12, 13, 14] . The current in-office ancillary services exception to the federal Stark laws has motivated many nonradiologist imagers to acquire imaging equipment and begin performing and interpreting examinations previously performed by radiologists [12, 13, 14] . A recent metaanalysis calculated the cost to Medicare of self-referral to be in the billions, and estimated that nonradiologist self-referrers of medical imaging are approximately 2.48 times more likely to order imaging than clinicians with no financial interest in imaging, which translates to an increased imaging utilization rate of 59.7% [15] .
Nonradiologists It is surprising that podiatrists increased utilization of MSK US without observable utilization increases by other physician providers that are likely to treat similar patients. Podiatrists, for example, increased their utilization by more than 14
times the increase among orthopedic surgeons during the same time period. It is possible that the marginal increase in revenue for performing more MSK US is more attractive to a podiatrist than to an orthopedic surgeon.
Private office MSK US examinations may be relatively free of scrutiny, peer review, validation or regulation. It is possible, particularly in a slow economy, that MSK US examinations are being performed more frequently to subsidize US equipment that has already been procured. When imaging equipment has already been purchased and is idle in practice settings, it may become used for situations and indications where it was not previously perceived as necessary.
These situations may not necessarily yield a patient benefit, but do increase the costs of delivering health care.
Evaluation of MSK US utilization by geographic region shows that only in one region have radiologists maintained or gained market share for MSK US. All other regions showed significant market share increases for nonradiologists ranging from 16% to 48% during the studied interval. The compound annual growth rate of MSK US in regions where nonradiologists had gained market share was in the double digits, ranging from 12.0 to 18.4%.
Our study could be considered limited in that it examines utilization only within the Medicare population and results may not be generalizable to the entire population. However, it is likely that analysis of different insurers will reflect a similar trend. This study also does not address the ranges of quality of MSK US studies. Analyses of billing records, such as this data set cannot describe image quality and indeed different study designs are recommended for such investigation. Indications for, and quality of, MSK US among different specialties are additional topics for further study.
In a healthcare climate where increased utilization deserves further scrutiny, this study has demonstrated significant utilization increases by specialties that are not traditional imagers who may be in a position to self-refer.
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